Yating Dian

611 total citations · 1 hit paper
22 papers, 248 citations indexed

About

Yating Dian is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Yating Dian has authored 22 papers receiving a total of 248 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 7 papers in Pulmonary and Respiratory Medicine and 7 papers in Oncology. Recurrent topics in Yating Dian's work include Ferroptosis and cancer prognosis (7 papers), COVID-19 Clinical Research Studies (6 papers) and SARS-CoV-2 and COVID-19 Research (4 papers). Yating Dian is often cited by papers focused on Ferroptosis and cancer prognosis (7 papers), COVID-19 Clinical Research Studies (6 papers) and SARS-CoV-2 and COVID-19 Research (4 papers). Yating Dian collaborates with scholars based in China, Canada and United States. Yating Dian's co-authors include Furong Zeng, Guangtong Deng, Yuming Sun, Yuming Sun, Xiang Chen, Jiayuan Le, Liping Jin, Minxue Shen, Lei Yao and Yongjia Liu and has published in prestigious journals such as SHILAP Revista de lepidopterología, Frontiers in Immunology and Journal of Investigative Dermatology.

In The Last Decade

Yating Dian

20 papers receiving 246 citations

Hit Papers

The molecular mechanism and therapeutic landscape of copp... 2025 2026 2025 5 10 15 20 25

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yating Dian China 9 85 74 52 52 39 22 248
Nenad Kunac Croatia 10 97 1.1× 24 0.3× 24 0.5× 65 1.3× 31 0.8× 22 212
Ariel M. Ley United States 7 72 0.8× 19 0.3× 44 0.8× 40 0.8× 34 0.9× 9 183
Jinping Lu China 10 172 2.0× 26 0.4× 38 0.7× 77 1.5× 62 1.6× 12 296
Mengying Bao China 5 129 1.5× 14 0.2× 59 1.1× 32 0.6× 43 1.1× 7 228
Bryan Laraway United States 7 193 2.3× 23 0.3× 30 0.6× 75 1.4× 33 0.8× 11 330
Eileen Frenzel Germany 7 142 1.7× 36 0.5× 29 0.6× 40 0.8× 45 1.2× 7 275
Anish Bhaswanth Chakka United States 9 87 1.0× 16 0.2× 44 0.8× 47 0.9× 52 1.3× 10 226
Georgi Manukjan Germany 11 88 1.0× 14 0.2× 32 0.6× 28 0.5× 20 0.5× 26 265
Rui An China 9 163 1.9× 18 0.2× 36 0.7× 78 1.5× 46 1.2× 16 286
Dimitris Matthaios Greece 11 105 1.2× 11 0.1× 52 1.0× 85 1.6× 74 1.9× 36 292

Countries citing papers authored by Yating Dian

Since Specialization
Citations

This map shows the geographic impact of Yating Dian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yating Dian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yating Dian more than expected).

Fields of papers citing papers by Yating Dian

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yating Dian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yating Dian. The network helps show where Yating Dian may publish in the future.

Co-authorship network of co-authors of Yating Dian

This figure shows the co-authorship network connecting the top 25 collaborators of Yating Dian. A scholar is included among the top collaborators of Yating Dian based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yating Dian. Yating Dian is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Guo, Ziyu, Lei Yao, Yuming Sun, et al.. (2025). The molecular mechanism and therapeutic landscape of copper and cuproptosis in cancer. Signal Transduction and Targeted Therapy. 10(1). 149–149. 26 indexed citations breakdown →
2.
Zhou, Qian, Yuming Sun, Yating Dian, et al.. (2025). Vorapaxar enhanced mitochondria-associated ferroptosis primes cancer immunotherapy via targeting FOXO1/HMOX1 axis. Cell Reports Medicine. 6(10). 102371–102371.
3.
Le, Jiayuan, Yating Dian, Deze Zhao, et al.. (2025). Single-cell multi-omics in cancer immunotherapy: from tumor heterogeneity to personalized precision treatment. Molecular Cancer. 24(1). 221–221. 9 indexed citations
4.
Yu, Meng, Qian Zhou, Yating Dian, et al.. (2025). Ferroptosis: A Targetable Vulnerability for Melanoma Treatment. Journal of Investigative Dermatology. 145(6). 1323–1344. 2 indexed citations
5.
Sun, Yuming, Qian Zhou, Yating Dian, et al.. (2025). Evaluating the causal effect of using glucagon-like peptide-1 receptor agonists on the risk of autoimmune diseases. Diabetes & Metabolic Syndrome Clinical Research & Reviews. 19(1). 103186–103186. 4 indexed citations
6.
Guo, Ziyu, Lei Yao, Yuming Sun, et al.. (2025). Targeting oxidative stress-mediated regulated cell death as a vulnerability in cancer. Redox Biology. 84. 103686–103686. 8 indexed citations
7.
Le, Jiayuan, Yuming Sun, Guangtong Deng, et al.. (2025). Immune checkpoint inhibitors in cancer patients with autoimmune disease: Safety and efficacy. Human Vaccines & Immunotherapeutics. 21(1). 2458948–2458948. 4 indexed citations
8.
Sun, Huiyan, Yu Meng, Lei Yao, et al.. (2024). Ubiquitin‐specific protease 22 controls melanoma metastasis and vulnerability to ferroptosis through targeting SIRT1/PTEN/PI3K signaling. SHILAP Revista de lepidopterología. 5(8). e684–e684. 6 indexed citations
9.
Sun, Yuming, et al.. (2024). Association of glucagon-like peptide-1 receptor agonists with risk of cancers-evidence from a drug target Mendelian randomization and clinical trials. International Journal of Surgery. 110(8). 4688–4694. 29 indexed citations
10.
Zhou, Qian, Yu Meng, Jiayuan Le, et al.. (2024). Ferroptosis: mechanisms and therapeutic targets. SHILAP Revista de lepidopterología. 5(12). e70010–e70010. 18 indexed citations
11.
Dian, Yating, et al.. (2024). Efficacy and safety of tebentafusp in patients with metastatic uveal melanoma: A systematic review and meta-analysis. Human Vaccines & Immunotherapeutics. 20(1). 2374647–2374647. 6 indexed citations
12.
Zhou, Qian, Yating Dian, Yi He, et al.. (2024). Propafenone facilitates mitochondrial-associated ferroptosis and synergizes with immunotherapy in melanoma. Journal for ImmunoTherapy of Cancer. 12(11). e009805–e009805. 6 indexed citations
13.
Sun, Yuming, Jiayuan Le, Yating Dian, et al.. (2024). Predictors of survival in immunotherapy‐based treatments in advanced melanoma: a meta‐analysis. International Journal of Dermatology. 64(1). 15–23. 2 indexed citations
14.
Jin, Liping, Yating Dian, Yuming Sun, et al.. (2024). Clinical characteristics and risk factors for ZF2001 fully vaccinated inpatients with COVID-19: A retrospective cohort study. Human Vaccines & Immunotherapeutics. 20(1). 2355683–2355683. 1 indexed citations
15.
Wang, Xiaomin, Yating Dian, Qian Zhou, et al.. (2023). Association of eosinopenia with worsening prognosis in hospitalized Azvudine-treated COVID-19 patients: a retrospective cohort study. Frontiers in Immunology. 14. 1320973–1320973. 3 indexed citations
16.
Sun, Yuming, Yating Dian, Qian Gao, & Guangtong Deng. (2023). Immunophenotyping characteristics and outcome of COVID‐19 patients: peripheral blood CD8+T cell as a prognostic biomarker for patients with Nirmatrelvir. Frontiers in Immunology. 14. 1227905–1227905.
17.
Dian, Yating, et al.. (2023). Lactate dehydrogenase predicts disease progression outcome in COVID-19 patients treated with Azvudine. Frontiers in Cellular and Infection Microbiology. 13. 1237277–1237277. 1 indexed citations
18.
Zhao, Deze, Yu Meng, Yating Dian, et al.. (2023). Molecular landmarks of tumor disulfidptosis across cancer types to promote disulfidptosis-target therapy. Redox Biology. 68. 102966–102966. 31 indexed citations
19.
Sun, Yuming, Liping Jin, Yating Dian, et al.. (2023). Oral Azvudine for hospitalised patients with COVID-19 and pre-existing conditions: a retrospective cohort study. EClinicalMedicine. 59. 101981–101981. 37 indexed citations
20.
Gao, Wenzhe, et al.. (2021). Expressional and Prognostic Value of S100A16 in Pancreatic Cancer Via Integrated Bioinformatics Analyses. Frontiers in Cell and Developmental Biology. 9. 645641–645641. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026